Previous Trials

XXXX XXXXXXX for Pediatric Psoriasis

Trial – Amgen | PPD A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Apremilast (CC-10004) in Pediatric Subjects from

Suffering from Atopic Dermatitis?

Trial – Syneos Health/Eli Lilly Eli Lilly and Company are conducting a study on an investigational drug called XXXXXXXXX as a possible treatment for moderate-to-severe

Hidradenitis Suppurativa Trial

Phase III Clinical Trial – Novartis A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year), safety, and tolerability

Do You Want To Boost Your Business?

drop us a line and keep in touch

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.